首页|碳离子治疗局限期小细胞肺癌患者效果评价

碳离子治疗局限期小细胞肺癌患者效果评价

扫码查看
目的 观察局限期小细胞肺癌(LS-SCLC)碳离子治疗联合化疗和全脑预防性光子放疗(PCI)的安全性和有效性.方法 选取2020-05-27-2023-04-13甘肃省武威肿瘤医院收治的经病理确诊的22例LS-SCLC患者为研究对象,碳离子处方剂量:72 Gy(RBE)/12次.所有患者碳离子放疗同步使用EP方案化疗,碳离子治疗结束疗效评价达到完全缓解或部分缓解的患者给予PCI治疗,观察患者治疗前后神经元特异性烯醇化酶(NSE)水平、治疗相关毒性、1年和2年局部控制率、无进展生存率、总生存率.结果 22例患者中21例患者完成了同步放化疗,1例患者因心肾综合征病史,肾功能分级3级未能接受化疗,其余患者耐受性良好.22例患者治疗前后NSE平均水平分别为(30.73±13.27)和(9.56±3.94)ng/mL,差异有统计学意义,t=7.168,P<0.001.随访5~35个月,1例患者拒绝PCI,在治疗后10个月出现多发性颅脑转移.1年和2年局部控制率分别为100.00%和92.31%;1年和2年总生存率分别为94.12%和84.71%,1年和2年无进展生存率分别为94.74%和77.73%.与碳离子治疗相关的不良反应有放射性肺炎(1级9例,2级2例)、食管炎(1级4例)、皮肤反应(1级1例),均为1、2级急性不良反应.结论 使用碳离子治疗联合化疗和PCI治疗LS-SCLC患者安全可靠,不良反应可耐受,局部控制率和生存率较好,但仍需要更多样本和更长时间随访进一步评估.
Evaluation of the effect of carbon ion radiotherapy on limited-stage small cell lung cancer
Objective To observe the safety and efficacy of carbon ion radiotherapy combined with concurrent chemotherapy and followed prophylactic cranial irradiation for limited.Methods A total of 22 pathologically confirmed limited-stage small cell lung cancer patients admitted to Gansu Wuwei Tumor Hospital from May 27,2020 to April 13,2023 were se-lected as the study objects,the prescribed dose of carbon ions was 72 Gy(RBE)/12 fractions.Carbon ion radiotherapy was used in all patients concurrent with EP regimen chemotherapy.Patients who achieved complete or partial response after carbon ion therapy were given prophylactic cranial irradiation.The level of neuron specific enolase,treatment-related toxic-ity,1-year and 2-year local control rate,progression-free survival rate,and overall survival rate were observed before and after treatment.Results Preliminary result of this pilot study showed 21 of the 22 patients completed concurrent chemo-radiotherapy.One patient did not receive chemotherapy due to comorbidity of cardiorenal syndrom,the other patients were well tolerated.The average NSE levels of 22 patients before and after treatment were(30.73±13.27)and(9.56±3.94)ng/ml,respectively,with statistically significant differences,t=7.168,P<0.001.Follow-up period was 5-35 months.One patient developed multiple brain metastasis who refused prophylactic cranial irradiation 10 months after treatment.1-year local control rate was 100.00%and 2-year local control rate was 92.31%.The 1-year and 2-year survival rates were 94.12%and 84.71%,and the 1-year and 2-year progression-free survival rates were 94.74%and 77.73%,respectively.Adverse reactions related to carbon ion therapy included radiation pneumonia(9 cases of grade 1 and 2 cases of grade 2),esophagitis(4 cases of grade 1),and skin reaction(1 case of grade 1),all of which were grade 1 and 2 toxicities.Conclu-sion Carbon ion radiotherapy with concurrent chemotherapy and prophylactic cranial irradiation for limited-stage small cell lung cancer is effective and feasiblity,with tolerable side effects and good local control rate and survival rate,but fur-ther evaluation with more cases and longer follow-up is still needed.

carbon ion therapylimited-stage small cell lung cancersecurityconcurrent radiochemotherapyprophylactic cranial irradiation

张一贺、张雁山、叶延程、秦天燕、李万国、潘鑫、王馨、杨钰玲、马彤、冯利霞

展开 >

甘肃省武威肿瘤医院重离子中心放疗科,甘肃武威 733000

甘肃省武威肿瘤医院肿瘤登记/随访中心,甘肃武威 733000

甘肃省武威肿瘤医院重离子中心放射技术室,甘肃武威 733000

甘肃省武威肿瘤医院重离子中心放射物理室,甘肃武威 733000

展开 >

碳离子治疗 局限期小细胞肺癌 安全性 同步放化疗 脑预防性照射

甘肃省科技厅重点研发甘肃省自然科学基金

19YF3FH001221JR7RH8962

2024

中华肿瘤防治杂志
中华预防医学会 山东省肿瘤防治研究院

中华肿瘤防治杂志

CSTPCD北大核心
影响因子:1.292
ISSN:1673-5269
年,卷(期):2024.31(14)